Pulse Biosciences (NASDAQ:PLSE) used its fourth-quarter and full-year 2025 earnings call to outline progress across its nanosecond pulsed field ablation (nsPFA) platform, including advancing two atria ...
Revolutionary AI-Powered Platform Replaces Legacy Systems with Zero Implementation Timeline—Limited to 5-7 Operators ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results